Commonwealth Equity Services LLC Sells 173 Shares of Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)
Commonwealth Equity Services LLC Sells 173 Shares of Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE)
Commonwealth Equity Services LLC trimmed its position in shares of Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE – Get Rating) by 1.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,662 shares of the company's stock after selling 173 shares during the period. Commonwealth Equity Services LLC owned approximately 0.25% of Invesco Dynamic Biotechnology & Genome ETF worth $557,000 at the end of the most recent quarter.
根據最近向證券交易委員會提交的 13F 表格，英聯邦股票服務有限責任公司在景順動態生物技術與基因組 ETF（NYSEARCA：PBE — 獲得評級）的股份部位下調了 1.8%。在此期間，該公司在賣出 173 股後擁有該公司股票的 9,662 股。英聯邦股票服務有限責任公司在最近一個季度結束時擁有景順動態生物技術及基因組 ETF 的 0.25%，價值 557,000 美元。
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Royal Bank of Canada grew its stake in shares of Invesco Dynamic Biotechnology & Genome ETF by 8.8% in the 1st quarter. Royal Bank of Canada now owns 73,653 shares of the company's stock valued at $4,568,000 after purchasing an additional 5,942 shares during the period. Artemis Wealth Advisors LLC bought a new stake in shares of Invesco Dynamic Biotechnology & Genome ETF in the 1st quarter valued at approximately $4,144,000. Cetera Advisor Networks LLC grew its stake in shares of Invesco Dynamic Biotechnology & Genome ETF by 23.3% in the 1st quarter. Cetera Advisor Networks LLC now owns 26,604 shares of the company's stock valued at $1,650,000 after purchasing an additional 5,019 shares during the period. YHB Investment Advisors Inc. grew its stake in shares of Invesco Dynamic Biotechnology & Genome ETF by 8.3% in the 1st quarter. YHB Investment Advisors Inc. now owns 23,309 shares of the company's stock valued at $1,446,000 after purchasing an additional 1,784 shares during the period. Finally, First Republic Investment Management Inc. grew its stake in shares of Invesco Dynamic Biotechnology & Genome ETF by 59.2% in the 1st quarter. First Republic Investment Management Inc. now owns 12,402 shares of the company's stock valued at $769,000 after purchasing an additional 4,612 shares during the period.
其他幾家機構投資者和對沖基金最近也增加或減少了他們在公司的股份。第一季，加拿大皇家銀行在景順動態生物技術與基因組 ETF 的股份增長 8.8%。加拿大皇家銀行在期內額外購買 5,942 股股份後，現擁有該公司 73,653 股價值 4,568,000 股股份。阿忒彌斯財富顧問有限責任公司在第一季度買入景順動態生物技術與基因組 ETF 股份的新股份，價值約為 4,144,000 美元。Cetera 顧問網絡有限責任公司在第一季度增長了 23.3％ 的景順動態生物技術和基因組 ETF 的股份權益。西泰亞顧問網絡有限責任公司在此期間額外購買 5,019 股股票後，擁有該公司股票價值為 1,650,000 美元的 26,604 股。YHB 投資顧問股份有限公司於第一季度增加了 8.3% 的景順動力生物技術及基因組 ETF 股份的股份。YHB 投資顧問股份有限公司在期內額外購買 1,784 股股份後，擁有該公司股票價值為 1,446,000 美元的 23,309 股。最後，第一共和投資管理股份有限公司於第一季增加景順動態生物科技及基因組 ETF 股份的股份增長 59.2%。第一共和國投資管理股份有限公司在期內額外購買 4,612 股股份後，擁有該公司股票價值 769,000 美元的 12,402 股股份。
Invesco Dynamic Biotechnology & Genome ETF Trading Up 2.1 %
景順動力生物科技及基因組 ETF 成交額上升 2.1%
PBE stock opened at $60.67 on Friday. Invesco Dynamic Biotechnology & Genome ETF has a 1-year low of $51.39 and a 1-year high of $77.36. The business's 50 day moving average is $61.02 and its 200-day moving average is $59.61.
PBE 股票於周五開盤 60.67 美元。景順動力生物科技及基因組 ETF 擁有一年低點 51.39 美元及一年新高 77.36 美元。該業務的 50 日移動平均線為 61.02 美元，而其 200 天移動平均線為 59.61 美元。
Invesco Dynamic Biotechnology & Genome ETF Company Profile
景順動力生物科技及基因組 ETF 公司簡介
PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.
寶碩動力生物科技及基因組投資組合（本基金）乃基於動態生物科技及基因組智能指數（「指數」）。本基金尋求一般符合指數價格及收益率的投資業績。該指數包括美國 30 家生物技術和基因組公司的股票。
Featured Articles
特色文章
- Get a free copy of the StockNews.com research report on Invesco Dynamic Biotechnology & Genome ETF (PBE)
- Should Investors Raise a Glass to Boston Beer Company?
- MarketBeat: Week in Review 10/17-10/21
- Snap Stock Falls As User Growth Slows To Single-Digits
- American Express Beats Earnings & Revenue Views, Raises Guidance
- The Institutions Spin Whirlpool Into Bargain Basement Territory
- 免費索取景順動態生物科技及基因組 ETF (PBE) 研究報告
- 投資者應該向波士頓啤酒公司舉杯嗎？
- 市場節拍：回顧中的一周
- 隨著用戶增長減慢到單位數字，Snap 庫存下降
- 美國運通擊敗收益和收入觀點，提高指導
- 機構旋轉漩渦進入討價還價的地下室領土
Want to see what other hedge funds are holding PBE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE – Get Rating).
想看看還有哪些對沖基金持有 PBE？ 訪問 Holdingschannel.com 以獲取景順動態生物技術及基因組 ETF（紐約 SEARCA：PBE — 獲取評級）的最新 13 樓文件和內幕交易。
Receive News & Ratings for Invesco Dynamic Biotechnology & Genome ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Dynamic Biotechnology & Genome ETF and related companies with MarketBeat.com's FREE daily email newsletter.
每日接收景順動態生物科技及基因組 ETF 的最新消息及評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊獲取景順動態生物技術和基因組 ETF 及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。